Effects of GS-3K8 and GINst15 on Acute Respiratory Illness
NCT ID: NCT03028077
Last Updated: 2017-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2014-10-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
NCT03172975
the Efficacy and Safety of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity
NCT03923894
Role of Zinc in Recurrent Acute Lower Respiratory Infections
NCT00536133
Therapeutic Zinc in Childhood Pneumonia
NCT00252304
Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants
NCT01571856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GS-3K8
GS-3K8 (6 cap/day, 500 mg/cap) for 12 weeks
GS-3K8
GS-3K8 (ultrafiltered red ginseng extract) 1 g/day
GINst15
GINst15 (6 cap/day, 500 mg/cap) for 12 weeks
GINst15
GINst15 (hydrolyzed ginseng extract) 1 g/day
Placebo
Placebo for 12 weeks
Placebo
Placebo 1 g/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GS-3K8
GS-3K8 (ultrafiltered red ginseng extract) 1 g/day
GINst15
GINst15 (hydrolyzed ginseng extract) 1 g/day
Placebo
Placebo 1 g/day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subjects with symptoms of upper respiratory tract infection
* Subjects with acute/chronic disease
* History of alcohol or substance abuse
* History of disease that could interfere with the test products or impede their absorption
* Subjects taking medications such as immune or upper respiratory tract infection related drug or functional foods
* Abnormal liver or kidney function tests
* Pregnant or lactating women and heavy smokers
* Being judged by the responsible physician of the local study center as unfit to participate in the study
39 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonbuk National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo-Wan Chae
Principal investigator, Clinical Trial Center for Functional Foods
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeong Hwan Hwang, M.D. Ph. D
Role: PRINCIPAL_INVESTIGATOR
Chonbuk National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Trial Center for Functional Foods Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTCF2_2014_GN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.